Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Potential impact of B cells on T cell function in multiple sclerosis.

Ireland S, Monson N.

Mult Scler Int. 2011;2011:423971. doi: 10.1155/2011/423971. Epub 2011 Mar 24.

PMID:
22096636
[PubMed]
Free PMC Article
2.

Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.

Lehmann-Horn K, Kronsbein HC, Weber MS.

Ther Adv Neurol Disord. 2013 May;6(3):161-73. doi: 10.1177/1756285612474333.

PMID:
23634189
[PubMed]
Free PMC Article
3.

CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.

Chen Z, Freedman MS.

Clin Immunol. 2008 Aug;128(2):219-27. doi: 10.1016/j.clim.2008.03.513. Epub 2008 May 22.

PMID:
18501678
[PubMed - indexed for MEDLINE]
4.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
5.

Use of rituximab in multiple sclerosis: current progress and future perspectives.

Reske D, Haupt WF.

Expert Rev Clin Immunol. 2008 Sep;4(5):573-82. doi: 10.1586/1744666X.4.5.573.

PMID:
20476960
[PubMed]
6.

The role of B cells in multiple sclerosis: implications for B-cell-targeted therapy.

Hirotani M, Niino M, Sasaki H.

Curr Med Chem. 2010;17(28):3215-22. Review.

PMID:
20666723
[PubMed - indexed for MEDLINE]
7.

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.

Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK.

Arch Neurol. 2005 Feb;62(2):258-64.

PMID:
15710854
[PubMed - indexed for MEDLINE]
8.

Spotlight on anti-CD20.

Waubant E.

Int MS J. 2008 Mar;15(1):19-25. Review.

PMID:
18713565
[PubMed - indexed for MEDLINE]
9.

Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, Stüve O.

Drugs. 2008;68(17):2445-68. doi: 10.2165/0003495-200868170-00004. Review.

PMID:
19016573
[PubMed - indexed for MEDLINE]
10.

The potential role of B cell-targeted therapies in multiple sclerosis.

Boster A, Ankeny DP, Racke MK.

Drugs. 2010 Dec 24;70(18):2343-56. doi: 10.2165/11585230-000000000-00000. Review.

PMID:
21142258
[PubMed - indexed for MEDLINE]
11.

B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases.

McLaughlin KA, Wucherpfennig KW.

Adv Immunol. 2008;98:121-49. doi: 10.1016/S0065-2776(08)00404-5. Review.

PMID:
18772005
[PubMed - indexed for MEDLINE]
12.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O.

Arch Neurol. 2009 Aug;66(8):1016-20. doi: 10.1001/archneurol.2009.157. Erratum in: Arch Neurol. 2009 Nov;66(11):1384.

PMID:
19667224
[PubMed - indexed for MEDLINE]
13.

Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.

Stinissen P, Medaer R, Raus J.

Mult Scler. 1998 Jun;4(3):203-11. Review.

PMID:
9762675
[PubMed - indexed for MEDLINE]
14.

Novel approaches and cutting edge immunotherapies in multiple sclerosis.

Bauman TM, Kasper LH.

Front Biosci. 2004 Sep 1;9:2302-22. Review.

PMID:
15353289
[PubMed - indexed for MEDLINE]
15.

[Rituximab in treatment for neuroimmunological diseases].

Schröder A, Ellrichmann G, Chehab G, Schneider M, Linker RA, Gold R.

Nervenarzt. 2009 Feb;80(2):155-6, 158-60, 162-5. doi: 10.1007/s00115-008-2663-3. Review. German.

PMID:
19183926
[PubMed - indexed for MEDLINE]
16.

[Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].

Jaśkiewicz E.

Postepy Hig Med Dosw (Online). 2004;58:472-82. Review. Polish.

PMID:
15765008
[PubMed - indexed for MEDLINE]
Free Article
17.

B cells as a target of immune modulation.

Hawker K.

Ann Indian Acad Neurol. 2009 Oct;12(4):221-5. doi: 10.4103/0972-2327.58275.

PMID:
20182568
[PubMed]
Free PMC Article
18.

Multiple sclerosis.

Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C.

Immunol Rev. 2005 Apr;204:208-31. Review.

PMID:
15790361
[PubMed - indexed for MEDLINE]
19.

Multiple sclerosis: a review of existing therapy and future prospects.

Khan OA.

J Pak Med Assoc. 1996 Jan;46(1):20-4. Review.

PMID:
8830165
[PubMed - indexed for MEDLINE]
20.

[Multiple sclerosis: epidemiology, molecular pathology and therapy].

Steck AJ, Schaeren-Wiemers N.

Schweiz Med Wochenschr. 1999 Nov 20;129(46):1764-8. Review. German.

PMID:
10603650
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk